Patrick Bednarski was born and raised in the United States. He studied biochemistry at the California Polytechnic State University in San Luis Obispo before moving to Seattle in 1981 to work on his dissertation under the supervision of Sidney D. Nelson in the Department of Medicinal Chemistry, School of Pharmacy at the University of Washington. The topic of his dissertation was the synthesis and testing of novel suicide inhibitors of the estrogen-producing enzyme aromatase. Following the completion of his PhD in 1986 he accepted an Alexander-von-Humboldt-Fellowship in Germany to work as a postdoc in the laboratories of Helmut Schönenberger in the Institute of Pharmacy at the University of Regensburg. In 1989 he began work towards his Habilitation in Pharmaceutical Chemistry at the University of Regensburg, which he completed in 1997. The theme of the Habilitation project was the development of new antitumor-active platinum complexes. He has been a member of the faculty of the Institute of Pharmacy at the University of Greifswald since 1998. Prof. Bednarski’s research interests centre on the development of new chemotherapies for cancer. In particular, areas of research are the design, synthesis and testing of new organic and inorganic compounds with cytotoxic activity in cell culture.
Biography Updated on 5 October 2009